REVIEW
The effect of maternal and infant factors on cord blood yield
Seyed Hadi Mousavi,
Saeid Abroun,
Morteza Zarrabi,
Mona Ahmadipanah,
Corresponding Author
Seyed Hadi Mousavi
Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
Correspondence
Seyed Hadi Mousavi, Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran 14177-44361, Iran.
Email: [email protected]
Search for more papers by this authorSaeid Abroun
Department of Hematology, School of Medical Sciences, Tarbiat Modarres University, Tehran, Iran
Search for more papers by this authorMorteza Zarrabi
Royan Stem Cell Technology Institute, Cord Blood Bank, Tehran, Iran
Search for more papers by this authorMona Ahmadipanah
Royan Stem Cell Technology Institute, Cord Blood Bank, Tehran, Iran
Search for more papers by this authorSeyed Hadi Mousavi,
Saeid Abroun,
Morteza Zarrabi,
Mona Ahmadipanah,
Corresponding Author
Seyed Hadi Mousavi
Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
Correspondence
Seyed Hadi Mousavi, Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran 14177-44361, Iran.
Email: [email protected]
Search for more papers by this authorSaeid Abroun
Department of Hematology, School of Medical Sciences, Tarbiat Modarres University, Tehran, Iran
Search for more papers by this authorMorteza Zarrabi
Royan Stem Cell Technology Institute, Cord Blood Bank, Tehran, Iran
Search for more papers by this authorMona Ahmadipanah
Royan Stem Cell Technology Institute, Cord Blood Bank, Tehran, Iran
Search for more papers by this authorAbstract
Umbilical cord blood (CB) can be used as an alternative hematopoietic stem cell source for transplantation in hematological malignancy and blood disorders. The success of transplantation is highly related to the levels of total nucleated cell and CD34+ cell counts. The evaluation of optimal conditions can decrease the rate of graft rejection due to low cell count and increases the quality of CB units (CBUs) in the blood bank and the success rate of engraftment. To this end, we review the maternal and infant parameters affecting the quality and quantity of CBUs.
REFERENCES
- 1Buckley RH, Schiff SE, Schiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999; 340: 508–516.
- 2McSweeney PA, Niederwieser D, Shizuru JA, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood. 2001; 97: 3390–3400.
- 3Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med. 2007; 357: 1472–1475.
- 4Grewal SS, Barker JN, Davies SM, Wagner JE. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood. 2003; 101: 4233–4244.
- 5Slatter M, Gennery A. Umbilical cord stem cell transplantation for primary immunodeficiencies. Expert Opin Biol Ther. 2006; 6: 555–565.
- 6Karanes C, Confer D, Walker T, Askren A, Keller C. Unrelated donor stem cell transplantation, the role of the National Marrow Donor Program. Oncology. 2003; 17: 1036–1038.
- 7Wagner JE, Rosenthal J, Sweetman R, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood. 1996; 88: 795–802.
- 8Anasetti C, Amos D, Beatty PG, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med. 1989; 320: 197–204.
- 9Wagner JE, Broxmeyer HE, Cooper S. Umbilical cord and placental blood hematopoietic stem cells: collection, cryopreservation, and storage. J Hematother. 1992; 1: 167–173.
- 10Armitage S, Warwick R, Fehily D, Navarrete C, Contreras M. Cord blood banking in London: the first 1000 collections. Bone Marrow Transplant. 1999; 24: 139–145.
- 11Gluckman E, Broxmeyer H, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989; 321: 1174–1178.
- 12O Brien TA, Tiedemann K, Vowels MR. No longer a biological waste product: umbilical cord blood. Med J Aust. 2006; 184: 407–410.
- 13Tse W, Laughlin MJ. Umbilical cord blood transplantation: a new alternative option. ASH Education Program Book. 2005; 2005; 377–383.
- 14Newburger PE, Quesenberry PJ. Umbilical cord blood as a new and promising source of unrelated-donor hematopoietic stem cells for transplantation. Curr Opin Pediatr. 1996; 8: 29–32.
- 15Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998; 339: 1565–1577.
- 16Rocha V, Wagner Jr JE, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med. 2000; 342: 1846–1854.
- 17Almici C, Carlo-Stella C, Wagner J, et al. Biologic and phenotypic analysis of early hematopoietic progenitor cells in umbilical cord blood. Leukemia. 1997; 11: 2143–2149.
- 18Mousavi SH, Abroun S, Soleimani M, Mowla SJ. Expansion of human cord blood hematopoietic stem/progenitor cells in three-dimensional Nanoscaffold coated with Fibronectin. Int J Hematol Oncol Stem Cell Res. 2015; 9: 72–79.
- 19Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med. 1997; 337: 373–381.
- 20Migliaccio AR, Adamson JW, Stevens CE, et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood. 2000; 96: 2717–2722.
- 21Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002; 100: 1611–1618.
- 22Kurtzberg J, Prasad VK, Carter SL, et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood. 2008; 112: 4318–4327.
- 23Gluckman E, Rocha V, Arcese W, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol. 2004; 32: 397–407.
- 24Bijou F, Ivanovic Z, Fizet D, et al. Neonatal sex and weight influence CD34+ cell concentration in umbilical cord blood but not stromal cell–derived factor 1-3′ A polymorphism. Cytotherapy. 2015; 17: 68–72.
- 25Page KM, Mendizabal A, Betz-Stablein B, et al. Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality. Transfusion. 2014; 54: 340–352.
- 26Omori A, Manabe M, Kudo K, et al. Influence of obstetric factors on the yield of mononuclear cells, CD34+ cell count and volume of placental/umbilical cord blood. J Obstet Gynaecol Res. 2010; 36: 52–57.
- 27Omori A, Takahashi K, Hazawa M, et al. Maternal and neonatal factors associated with the high yield of mononuclear low-density/CD34+ cells from placental/umbilical cord blood. Tohoku J Exp Med. 2008; 215: 23–32.
- 28Mancinelli F, Tamburini A, Spagnoli A, et al. Optimizing umbilical cord blood collection: impact of obstetric factors versus quality of cord blood units. Transplant Proc. 2006; 38: 1174–1176.
- 29Askari S, Miller J, Chrysler G, McCullough J. Impact of donor-and collection-related variables on product quality in ex utero cord blood banking. Transfusion. 2005; 45: 189–194.
- 30Aroviita P, Teramo K, Hiilesmaa V, Kekomäki R. Cord blood hematopoietic progenitor cell concentration and infant sex. Transfusion. 2005; 45: 613–621.
- 31Nakagawa R, Watanabe T, Kawano Y, et al. Analysis of maternal and neonatal factors that influence the nucleated and CD34+ cell yield for cord blood banking. Transfusion. 2004; 44: 262–267.
- 32Aufderhaar U, Holzgreve W, Danzer E, et al. The impact of intrapartum factors on umbilical cord blood stem cell banking. J Perinat Med. 2003; 31: 317–322.
- 33Ballen K, Wilson M, Wuu J, et al. Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units. Bone Marrow Transplant. 2001; 27: 7–14.
- 34Surbek DV, Visca E, Steinmann C, et al. Umbilical cord blood collection before placental delivery during cesarean delivery increases cord blood volume and nucleated cell number available for transplantation. Am J Obstet Gynecol. 2000; 183: 218–221.
- 35Shlebak A, Roberts I, Stevens T, et al. The impact of antenatal and perinatal variables on cord blood haemopoietic stem/progenitor cell yield available for transplantation. Br J Haematol. 1998; 103: 1167–1171.
- 36McGuckin C, Basford C, Hanger K, Habibollah S, Forraz N. Cord blood revelations—the importance of being a first born girl, big, on time and to a young mother! Early Hum Dev. 2007; 83: 733–741.
- 37Pope B, Hokin B, Grant R. Effect of umbilical cord blood prefreeze variables on postthaw viability. Transfusion. 2015; 55: 629–635.
- 38Bonab M, Alimoghaddam K, Goliaei Z, Ghavamzadeh A. Which factors can affect cord blood variables? Transfusion. 2004; 44: 690–693.
- 39Omori A, Hirai M, Chiba T, et al. Quality-assessments of characteristics of placental/umbilical cord blood associated with maternal age-and parity-related factor. Transfus Apher Sci. 2012; 46: 7–13.
- 40Al-Sweedan SA, Musalam L, Obeidat B. Factors predicting the hematopoietic stem cells content of the umbilical cord blood. Transfus Apher Sci. 2013; 48: 247–252.
- 41Chivu M, Nastasia S, Sultana C, et al. Optimizing donor selection in order to establish a cord blood banking facility: maternal and obstetric factors impact. Cent Eur J Med. 2007; 2: 180–189.
- 42Wu J, Liao C, Chen J, et al. [Analysis of maternal and neonatal factors associated with hematopoietic reconstruction potential in umbilical cord blood units]. J Exp Hematol Chin Assoc Pathophysiol. 2010; 18: 1535–1541.
- 43Wen S-H, Zhao W-L, Lin P-Y, Yang K-L. Associations among birth weight, placental weight, gestational period and product quality indicators of umbilical cord blood units. Transfus Apher Sci. 2012; 46: 39–45.
- 44Solves P, Perales A, Moraga R, et al. Maternal, neonatal and collection factors influencing the haematopoietic content of cord blood units. Acta Haematol. 2004; 113: 241–246.
- 45Donaldson C, Armitage WJ, Laundy V, et al. Impact of obstetric factors on cord blood donation for transplantation. Br J Haematol. 1999; 106: 128–132.
- 46George TJ, Sugrue MW, George SN, Wingard JR. Factors associated with parameters of engraftment potential of umbilical cord blood. Transfusion. 2006; 46: 1803–1812.
- 47Solves P, López M, Mirabet V, et al. Characteristics of umbilical cord blood units collected from preterm deliveries. Gynecol Obstet Invest. 2008; 68: 181–185.
- 48Solves P, Perales A, Mirabet V, et al. Optimizing donor selection in a cord blood bank. Eur J Haematol. 2004; 72: 107–112.
- 49Jones J, Stevens CE, Rubinstein P, et al. Obstetric predictors of placental/umbilical cord blood volume for transplantation. Am J Obstet Gynecol. 2003; 188: 503–509.
- 50Chandra T, Afreen S, Kumar A, Singh U, Gupta A. Does umbilical cord blood-derived CD34+ cell concentration depend on the weight and sex of a full-term infant? J Pediatr Hematol Oncol. 2012; 34: 184–187.
- 51Solves P, Larrea L, Soler MA, Mirabet V. Relationship between gestational age and cord blood quality. Transfusion. 2001; 41: 302–303.
- 52Nunes RD, Zandavalli FM. Association between maternal and fetal factors and quality of cord blood as a source of stem cells. Rev Bras Hematol Hemoter. 2014.
- 53Cairo MS, Wagner EL, Fraser J, et al. Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report. Transfusion. 2005; 45: 856–866.
- 54Wyrsch A, dalle Carbonare V, Jansen W, et al. Umbilical cord blood from preterm human fetuses is rich in committed and primitive hematopoietic progenitors with high proliferative and self-renewal capacity. Exp Hematol. 1999; 27: 1338–1345.
- 55Thilaganathan B, Nicolaides KH, Morgan G. Subpopulations of CD34-positive haemopoietic progenitors in fetal blood. Br J Haematol. 1994; 87: 634–636.
- 56Juutistenaho S, Eskola M, Sainio S, Aranko K, Kekomäki R. Association of stress-related perinatal factors and cord blood unit hematopoietic progenitors is dependent on delivery mode. Transfusion. 2010; 50: 663–671.
- 57Gasparoni A, Ciardelli L, Avanzini MA, et al. Immunophenotypic changes of fetal cord blood hematopoietic progenitor cells during gestation. Pediatr Res. 2000; 47: 825–829.
- 58Surbek DV, Steinmann C, Tichelli A, Wodnar-Filipowicz A, Holzgreve W. Decreased cord blood yield in post-term pregnancy: a comparative study. Br J Haematol. 2000; 110: 235–237.
- 59Surbek DV, Steinmann C, Bürk M, et al. Developmental changes in adhesion molecule expressions in umbilical cord blood CD34+ hematopoietic progenitor and stem cells. Am J Obstet Gynecol. 2000; 183: 1152–1157.
- 60Surbek D, Holzgreve W, Steinmann C, et al. Preterm birth and the availability of cord blood for HPC transplantation. Transfusion. 2000; 40: 817–820.
- 61Shields LE, Andrews RG. Gestational age changes in circulating CD34+ hematopoietic stem/progenitor cells in fetal cord blood. Am J Obstet Gynecol. 1998; 178: 931–937.
- 62Jan RH, Wen SH, Shyr MH, Chiang BL. Impact of maternal and neonatal factors on CD34+ cell count, total nucleated cells, and volume of cord blood. Pediatr Transplant. 2008; 12: 868–873.
- 63Urciuoli P, Passeri S, Ceccarelli F, et al. Pre-birth selection of umbilical cord blood donors. Blood Transfus. 2010; 8: 36–43.
- 64Surbek DV, Danzer E, Steinmann C, et al. Effect of preeclampsia on umbilical cord blood hematopoietic progenitor-stem cells. Am J Obstet Gynecol. 2001; 185: 725–729.
- 65Louis I, Wagner E, Dieng MM, et al. Impact of storage temperature and processing delays on cord blood quality: discrepancy between functional in vitro and in vivo assays. Transfusion. 2012; 52: 2401–2405.
- 66Yang H, Loutfy MR, Mayerhofer S, Shuen P. Factors affecting banking quality of umbilical cord blood for transplantation. Transfusion. 2011; 51: 284–292.
- 67Manegold G, Meyer-Monard S, Tichelli A, et al. Cesarean section due to fetal distress increases the number of stem cells in umbilical cord blood. Transfusion. 2008; 48: 871–876.
- 68Bassiouny M, El-Chennawi F, Mansour A, Yahia S, Darwish A. Optimal method for collection of umbilical cord blood: an Egyptian trial for a public cord blood bank. Transfusion. 2015; 55: 1263–1268.
- 69Sparrow RL, Cauchi JA, Ramadi LT, Waugh CM, Kirkland MA. Influence of mode of birth and collection on WBC yields of umbilical cord blood units. Transfusion. 2002; 42: 210–215.
- 70Yamada T, Okamoto Y, Kasamatsu H, et al. Factors affecting the volume of umbilical cord blood collections. Acta Obstet Gynecol Scand. 2000; 79: 830–833.
- 71Chandra T, Afreen S, Kumar A, Singh U. Correlation of umbilical cord blood volume with CD34+ cells concentration. Int J Blood Transfus Immunohematol. 2012; 1: 11–15.
10.5348/ijbti-2011-3-OA-3 Google Scholar
- 72Vettenranta K, Piirto I, Saarinen-Pihkala UM. The effects of the mode of delivery on the lymphocyte composition of a placental/cord blood graft. J Hematother. 1997; 6: 491–493.
- 73Pope B, Hokin B, Grant R. Effect of maternal iron status on the number of CD34+ stem cells harvested from umbilical cord blood. Transfusion. 2014; 54: 1876–1880.
- 74Aroviita P, Teramo K, Hiilesmaa V, Westman P, Kekomäki R. Birthweight of full-term infants is associated with cord blood CD34+ cell concentration. Acta Paediatr. 2004; 93: 1323–1329.
- 75Screnci M, Murgi E, Carmini D, et al. Related cord blood banking for haematopoietic stem cell transplantation. Transfus Med. 2010; 20: 185–190.
- 76Solves P, Fillol M, López M, et al. Mode of collection does not influence haematopoietic content of umbilical cord blood units from caesarean deliveries. Gynecol Obstet Invest. 2005; 61: 34–39.
- 77Solves P, Moraga R, Saucedo E, et al. Comparison between two strategies for umbilical cord blood collection. Bone Marrow Transplant. 2003; 31: 269–273.
- 78Pafumi C, Farina M, Maggi I, et al. Influence of the kind of delivery on umbilical cord blood collection. Haematologia. 2001; 31: 341–345.
- 79Lim F, Van Winsen L, Willemze R, Kanhai H, Falkenburg J. Influence of delivery on numbers of leukocytes, leukocyte subpopulations, and hematopoietic progenitor cells in human umbilical cord blood. Blood Cells. 1993; 20: 547–558; discussion 558–549.
- 80Pope B, Mitsakos K, Bilgin A, Hokin B, Grant R. Predicting overall viability of cord blood harvests. Transfusion. 2012; 52: 1079–1085.
- 81Ballen KK, Kurtzberg J, Lane TA, et al. Racial diversity with high nucleated cell counts and CD34 counts achieved in a national network of cord blood banks. Biol Blood Marrow Transplant. 2004; 10: 269–275.
- 82Abdul Wahid FS, Nasaruddin MZ, Idris M, et al. Effects of preeclampsia on the yield of hematopoietic stem cells obtained from umbilical cord blood at delivery. J Obstet Gynaecol Res. 2012; 38: 490–497.
- 83Keersmaekers CL, Mason BA, Keersmaekers J, Ponzini M, Mlynarek RA. Factors affecting umbilical cord blood stem cell suitability for transplantation in an in utero collection program. Transfusion. 2014; 54: 545–549.
- 84Lim FT, Scherjon SA, van Beckhoven JM, et al. Association of stress during delivery with increased numbers of nucleated cells and hematopoietic progenitor cells in umbilical cord blood. Am J Obstet Gynecol. 2000; 183: 1144–1151.
- 85Díaz A, Castro A, Villaescusa R. Collection, processing and cryopreservation of umbilical cord blood for unrelated transplantation. Bone Marrow Transplant. 2000; 26: 1263–1270.
- 86Pafumi C, Farina M, Bandiera S, et al. Differences in umbilical cord blood units collected during cesarean section, before or after the delivery of the placenta. Gynecol Obstet Invest. 2001; 54: 73–77.
- 87Kurtzberg J, Cairo MS, Fraser JK, et al. Results of the cord blood transplantation (COBLT) study unrelated donor banking program. Transfusion. 2005; 45: 842–855.
- 88Savarese TM, Strohsnitter WC, Low HP, et al. Correlation of umbilical cord blood hormones and growth factors with stem cell potential: implications for the prenatal origin of breast cancer hypothesis. Breast Cancer Res. 2007; 9: R29.
- 89Strohsnitter WC, Savarese TM, Low HP, et al. Correlation of umbilical cord blood haematopoietic stem and progenitor cell levels with birth weight: implications for a prenatal influence on cancer risk. Br J Cancer. 2008; 98: 660–663.
- 90Pafumi C, Zizza G, Russo A, et al. Placing the newborn on the maternal abdomen increases the volume of umbilical cord blood collected. Clin Lab Haematol. 2001; 23: 397–399.
- 91Grisaru D, Deutsch V, Pick M, et al. Placing the newborn on the maternal abdomen after delivery increases the volume and CD34+ cell content in the umbilical cord blood collected: an old maneuver with new applications. Am J Obstet Gynecol. 1999; 180: 1240–1243.
- 92Santos SV, Barros SM, Santos MS, et al. Predictors of high-quality cord blood units. Transfusion. 2016; 56: 2030–2036.
- 93Podestà M, Bruschettini M, Cossu C, et al. Preterm cord blood contains a higher proportion of immature hematopoietic progenitors compared to term samples. PloS One. 2015; 10: e0138680.
